HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abbas Mirshafiey Selected Research

Proteins (Proteins, Gene)

4/2016In Vitro Effects of Propranolol on T Helper Type 1 Cytokine Profile in Human Leukemic T Cells.
12/2015A Live Vector Expressing HPV16 L1 Generates an Adjuvant-Induced Antibody Response In-vivo.
10/2015Effect of Genistein and L-Carnitine and Their Combination on Gene Expression of Hepatocyte HMG-COA Reductase and LDL Receptor in Experimental Nephrotic Syndrome.
1/2013Influenza Virus-like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With A/PR8 (H1N1) and A/HK (H3N2) Viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abbas Mirshafiey Research Topics

Disease

39Multiple Sclerosis
06/2023 - 01/2005
30Rheumatoid Arthritis
02/2022 - 01/2005
20Inflammation (Inflammations)
01/2022 - 07/2005
17Neoplasms (Cancer)
01/2022 - 10/2004
11Ankylosing Spondylitis
05/2023 - 06/2015
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2019 - 01/2005
9Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2005
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 09/2012
6Pain (Aches)
01/2021 - 03/2013
6Breast Neoplasms (Breast Cancer)
07/2019 - 04/2015
6Proteinuria
10/2015 - 08/2002
5Nephrotic Syndrome (Syndrome, Nephrotic)
01/2017 - 07/2007
4COVID-19
01/2023 - 12/2021
4Body Weight (Weight, Body)
01/2022 - 01/2015
4Neoplasm Metastasis (Metastasis)
01/2022 - 10/2007
4Infections
01/2021 - 01/2013
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2020 - 10/2017
4Relapsing-Remitting Multiple Sclerosis
01/2018 - 01/2014
4Glomerulonephritis
01/2015 - 06/2005
4Edema (Dropsy)
03/2014 - 01/2005
3Common Variable Immunodeficiency
12/2019 - 01/2016
3Rheumatic Diseases (Rheumatism)
02/2019 - 08/2005
3Communicable Diseases (Infectious Diseases)
02/2017 - 10/2007
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2016 - 04/2014
3Fibrosarcoma
01/2014 - 10/2004
3Asthma (Bronchial Asthma)
10/2012 - 12/2008
3Nephrosis
08/2005 - 08/2002
2Cytokine Release Syndrome
12/2022 - 12/2021
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2021
2Neuroinflammatory Diseases
10/2021 - 09/2010
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021 - 08/2009
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020 - 08/2015
2Atherosclerosis
11/2020 - 04/2018
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2020 - 06/2015
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020 - 01/2019
2Diabetes Complications
11/2019 - 06/2019
2Primary Immunodeficiency Diseases
01/2016 - 06/2014
2Demyelinating Diseases (Demyelinating Disease)
09/2015 - 02/2014
2Disease Progression
09/2015 - 12/2012
2Atopic Dermatitis (Atopic Eczema)
08/2015 - 06/2011
2Arthritis (Polyarthritis)
01/2015 - 12/2008

Drug/Important Bio-Agent (IBA)

38mannuronic acidIBA
05/2023 - 01/2005
22Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2023 - 10/2004
19guluronic acidIBA
01/2023 - 09/2015
19CytokinesIBA
12/2022 - 12/2012
15Therapeutic UsesIBA
10/2019 - 08/2005
9Interleukin-17 (Interleukin 17)IBA
12/2022 - 10/2017
7EnzymesIBA
01/2018 - 06/2010
5Interleukin-4 (Interleukin 4)IBA
06/2023 - 04/2014
5Matrix Metalloproteinases (MMPs)IBA
01/2020 - 10/2004
5Vitamin DFDA LinkGeneric
11/2019 - 04/2016
4Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2004
4Biomarkers (Surrogate Marker)IBA
10/2021 - 02/2016
4Transcription Factors (Transcription Factor)IBA
06/2020 - 05/2014
4AntioxidantsIBA
04/2020 - 01/2009
4Blood Glucose (Blood Sugar)IBA
01/2020 - 01/2019
4Insulin (Novolin)FDA Link
01/2020 - 01/2019
4AntigensIBA
01/2019 - 04/2014
4Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2019 - 11/2007
4ProstaglandinsIBA
01/2018 - 12/2010
4Interleukin-22 (IL-22)IBA
07/2016 - 01/2015
4Proteins (Proteins, Gene)FDA Link
04/2016 - 01/2013
4CreatinineIBA
10/2015 - 08/2002
4LipidsIBA
03/2014 - 07/2007
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 12/2008
3Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2023 - 01/2018
3ChemokinesIBA
01/2021 - 08/2014
3Toll-Like Receptors (Toll-Like Receptor)IBA
06/2019 - 01/2016
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2017 - 06/2005
3Anti-Citrullinated Protein AntibodiesIBA
01/2017 - 08/2013
3AntibodiesIBA
12/2016 - 04/2014
3Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2016 - 04/2012
3Inosine Triphosphate (ITP)IBA
09/2016 - 04/2014
3Antigen-Antibody Complex (Immune Complex)IBA
02/2016 - 06/2005
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2015 - 10/2004
3AutoantigensIBA
01/2015 - 08/2013
3LeukotrienesIBA
03/2014 - 06/2010
3Free RadicalsIBA
01/2014 - 01/2009
3CholesterolIBA
08/2005 - 08/2002
2Docosahexaenoic AcidsIBA
06/2023 - 01/2018
2Antiviral Agents (Antivirals)IBA
01/2023 - 12/2021
2Amyloid beta-PeptidesIBA
01/2022 - 06/2013
2Interleukin-8 (Interleukin 8)IBA
01/2022 - 01/2020
2TNF Receptor-Associated Factor 6 (TRAF6)IBA
10/2021 - 06/2020
2VaccinesIBA
12/2019 - 12/2015
2HexosaminesIBA
11/2019 - 01/2019
2NF-kappa B (NF-kB)IBA
11/2019 - 11/2017
2Toll-Like Receptor 2IBA
06/2019 - 04/2018
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2018 - 10/2017
2Malondialdehyde (Propanedial)IBA
02/2017 - 10/2016
2Superoxide DismutaseIBA
02/2017 - 10/2016
2Rheumatoid FactorIBA
01/2017 - 01/2017
2AlginatesIBA
01/2017 - 06/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015 - 01/2004
2GenisteinIBA
10/2015 - 01/2014

Therapy/Procedure

22Therapeutics
01/2023 - 08/2002
8Oral Administration
01/2021 - 04/2015
2Aftercare (After-Treatment)
05/2023 - 01/2019
2Injections
01/2022 - 04/2020
2Intravenous Injections
01/2017 - 01/2004